Why are hypomethylating agents or low-dose cytarabine and venetoclax so effective?

Title
Why are hypomethylating agents or low-dose cytarabine and venetoclax so effective?
Authors
Keywords
-
Journal
CURRENT OPINION IN HEMATOLOGY
Volume 26, Issue 2, Pages 71-76
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2019-01-30
DOI
10.1097/moh.0000000000000485

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now